Abstract
NRXN1 encodes thousands of splicing variants categorized into long NRXN1, short NRXN1ß and extremely short NRXN1, which exert differential roles in neuronal excitation inhibition. NRXN1 deletions are common in autism spectrum disorder (ASD) and other neurodevelopmental neuropsychiatric disorders. We derived induced pluripotent stem cells (iPSCs) from one sibling control and two ASD probands carrying NRXN1+ -, using non-integrating Sendai viral method. All iPSCs highly expressed pluripotency markers and could be differentiated into ectodermal mesodermal endodermal cells. The genotype and karyotype of the iPSCs were validated by whole genome SNP array. The availability of the iPSCs offers an opportunity for understanding NRXN1 function in human neurons and in ASD.
| Original language | English (Ireland) |
|---|---|
| Article number | 102222 |
| Journal | Stem Cell Research |
| Volume | 52 |
| DOIs | |
| Publication status | Published - 1 Feb 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Authors (Note for portal: view the doc link for the full list of authors)
- Authors
- Ding Y;O'Brien A;de la Cruz BM;Yang M;Fitzgerald J;Yang G;Li W;McInerney V;Krawczyk J;Lynch SA;Howard L;Allen NM;O'Brien T;Gallagher L;Shen S;
Fingerprint
Dive into the research topics of 'Derivation of iPSC lines from two patients with autism spectrum disorder carrying NRXN1 deletion (NUIGi041-A, NUIG041-B; NUIGi045-A) and one sibling control (NUIGi042-A, NUIGi042-B).'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver